Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

meta-Hydroxynorephedrine

From Wikipedia, the free encyclopedia
meta-Hydroxynorephedrine
Clinical data
Other namesm-hydroxypropadrine
m-hydroxyphenylpropanolamine
α-methyl-m-octopamine
3,β-dihydroxyamphetamine
3,β-dihydroxy-α-methylphenethylamine
ATC code
  • None
Legal status
Legal status
  • In general: non-regulated
Identifiers
  • 3-(2-amino-1-hydroxypropyl)phenol
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC9H13NO2
Molar mass167.208 g·mol−1
3D model (JSmol)
  • OC(c1cc(O)ccc1)C(N)C
  • InChI=1S/C9H13NO2/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6,9,11-12H,10H2,1H3
  • Key:WXFIGDLSSYIKKV-UHFFFAOYSA-N

meta-Hydroxynorephedrine or 3-hydroxynorephedrine, also known as 3,β-dihydroxyamphetamine, is an adrenergic drug of the amphetamine class which was patented as a vasopressor and nasal decongestant but was never marketed.[1][2] It is the racemic form of the sympathomimetic drug metaraminol.

See also

[edit]

References

[edit]
  1. Macdonald F (1997). Dictionary of Pharmacological Agents. CRC Press. p. 106. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.
  2. Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. 15 January 2013. p. 2110. ISBN 978-0-8155-1526-5. Retrieved 24 April 2012.